As of 2025-02-17, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (38.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -300.5%.
The range of the Relative Valuation is (42.35) - (34.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 23.2x | 18.1x |
| Forward P/E multiples | 28.7x - 35.3x | 33.6x |
| Fair Price | (42.35) - (34.16) | (38.09) |
| Upside | -322.9% - -279.8% | -300.5% |
| Date | P/E |